ALK and lymphoma: In contrast, the RAG competent CD4NA/OT1 line do produce ALK+ lymphomas, with a peripheral rather than thymic presentation, and a mean survival of 181 days (versus 88 days for the CD4NA mice (P=0.0001, Student's t-test); Fig. 4a).